Nervive, Inc. Company

Nervive is a stock-based Delaware C-corp that develops a new treatment for brain ischemia. Its primary product, VitalFlow Stimulator, is non-invasive platform technology that treats conditions of brain ischemia such as cerebral artery vasospasm, ischemic stroke, and traumatic brain injury. Founded in 2013, Nervive is headquartered in Akron, Ohio.
Technology: NeuroTech
Industry: Health Care, Medical, Wellness
Headquarters: Akron, Ohio, United States
Founded Date: 2013-12-31
Employees Number: 1-10
Investors Number: 3
Total Funding: $3.6M
Estimated Revenue: Less than $1M
Last Funding Type: Grant

Visit Website
mgroh@nervive.com
Register and Claim Ownership